Definitive Contract 75A50125C00016
Award Date
9/30/25
Potential Completion Date
8/1/29
Potential Value
$20M
Awardee
Prenosis, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60616, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $749,000 firm fixed price contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Prenosis, Inc., a self-certified small disadvantaged business. The contract, which is not set aside, is for a 3-site clinical study to assess the feasibility of implementing the Sepsis Immunoscore diagnostic test in hospital environments and evaluate its diagnostic performance. Prenosis, Inc. is a Chicago-based company that...
This is a $4,308,629.81 cost-plus-fixed-fee contract awarded by the Defense Threat Reduction Agency (DTRA) to Prenosis, Inc., a self-certified small disadvantaged business based in Chicago, Illinois. The contract is for research and development services to develop a predictive analytics point-of-care system to predict disease severity due to infection. This is not a set-aside contract. The contract has a period of performance ending on September 30, 2025. Prenosis, Inc. has received multiple...
This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Inflammatix, Inc., a small disadvantaged business. The $749,999 firm fixed-price contract supports research and development for the Triverity cartridge, a diagnostic tool focused on infection severity and sepsis detection, under Area of Interest #2 of ASPR's Easy Broad Agency Announcement. The...
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Inflammatix, Inc., a self-certified small disadvantaged business. The contract is for the development of the HOSTDX-Sepsis diagnostic test, a rapid point-of-care test that analyzes the host immune response to detect and classify sepsis. The contract has a firm fixed price of $510,000.00 and a completion date of November 30, 2021....
This is a $27,992,718.00 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Inflammatix, Inc., a self-certified small disadvantaged business, for the development of a full stack of host-response solutions to address infectious disease testing for acute infections and sepsis. The contract is for the period of September 25, 2019 through May 7, 2027 and is a cost-sharing arrangement. No set-aside was used for this award....
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pattern Bioscience, Inc., a biotechnology company, to develop a rapid pathogen identification and antimicrobial susceptibility testing platform. The contract, valued at $40,937,536.73, is for the verification, clinical evaluation, and U.S. Food and Drug Administration (FDA) clearance of this culture-free, phenotypic diagnostic platform. The contract is a...
This is a firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Gnomx Corp., a self-certified small disadvantaged business, on September 9, 2024. The contract has a ceiling value of $749,700.00 and a completion date of October 30, 2026. The purpose of the contract is to validate a host-based diagnostic that provides an immune dysregulation score to be compatible with a point-of-care device for community...
<p>This is a $12,606,489.57 Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to AD Astra Diagnostics, Inc. for the research and development of a CLIA-waived ubiquitous early sepsis detection and severity assessment system for use in ambulance, pre-hospital, and post-discharge settings. The contract has an ultimate completion date of December 15, 2027 and does not have a set-aside designation.</p>
<p>The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a Firm Fixed Price contract to Proactive Diagnostics Inc., a small disadvantaged business, for Research and Development of the Q-Sense platform, an enabling technology for multiplexed home testing. The contract has a ceiling value of $720,580.39 and a period of performance ending on April 14, 2024. There is no set-aside designation for this award.</p>
This contract, awarded by the Office of the Assistant Secretary for Preparedness and Response (a civilian agency), will provide $749,000.00 in support to Gen1E Lifesciences Inc., a U.S. company, for the advancement of patient stratification and endotyping approaches as it develops GEN-1124, a novel treatment for Acute Respiratory Distress Syndrome (ARDS). The contract, which does not have a set-aside designation, is a definitive, firm fixed-price contract with a completion date of January 30,...